Salbutamol (albuterol) Flashcards
What is the trade name of salbutamol?
Ventolin
What is the classification of salbutamol?
bronchodilator
beta2-selective adrenergic agonist (sympathomimetic)
How is salbutamol supplied?
2.5 mL nebule (1mg/mL)
MDI 100 mcg/spray
Combivent (Ventolin 2.5 mg/Atrovent 500 mcg)
What is the MOA (pharmacodynamics) of salbutamol?
- Selectively stimulates beta-adrenergic receptors of the lungs, uterus, and vascular smooth muscle.
- Bronchodilation results from relaxation of the vascular smooth muscles, which relieves bronchospasm and reduces airway resistance.
- Higher doses will drive serum potassium (K+) into the cells.
List the indications for salbutamol?
- Bronchospasm due to asthma, chronic bronchitis, other chronic broncho-pulmonary disorders and anaphylaxis
- Hyperkalemia
What is the salbutamol dosage for Bronchospasm?
Adult-2.5-5.0 mg NEB – repeat prn
-MDI 10 puffs (100mcg) with spacer q 5 min.
Pediatric-<10 kg = 1.25 mg;
10 - 20 kg = 2.5 mg;
>20 kg = 5 mg
(MDI 1 – 2 puffs q4h prn if over 4 y/o)
Less then 4 y/o use nebulization only
What is the IV/IO salbutamol dose for asthma?
4mcg/kg IV/IO over 2 to 5 minutes q 15 minutes PRN to a max single dose of 250mcg.
**Only given AFTER Pt has received Mag, Dex, Atrovent/Ventolin NEB/MDI and EPI x 3.
How should a salbutamol (Ventolin) MDI be administered?
Wait 30 seconds between each puff to allow MDI to recharge; invert canister numerous times and depress canister 3 times, directed away from pt, prior to administration; as pt begins to inhale deliver one puff into the chamber; allow pt to breathe into the chamber 5 times before removing it; instruct pt hold their breath for 5 – 10 seconds with each inhale.
What is the dosage for salbutamol with a hyperkalemic patient?
NEB 10-20 mg (preferably 5mg/ml) nebulized over 15 minutes PRN.
MDI 10 puffs (100mcg) with a spacer
q 15 minutes PRN.
IV 4mcg/kg to a single max of 250mcg over 2 – 5 minutes. Do not repeat.
What’s the contraindication for salbutamol?
Hypersensitivity!
What are some of the precautions in the use of salbutamol.
- Congestive heart failure
- Cardiovascular disease: Myocardial Infarction, Angina, cardiac dysrhythmias, hypertension, tachycardia associated with digitalis toxicity
- Diabetes mellitus: risk of drug induced hyperglycemia
- Hypokalemia: risk further reducing serum potassium levels and possible adverse cardiovascular events
What are some things to note in regards to salbutamol?
-Administer continuously during rapid transport in patients who are in severe respiratory distress
-When used at recommended doses, short-acting-beta-agonists (SABAs) are generally devoid of adverse effects.
-Cardiac stimulation and tremors are most likely with systemic therapy and higher-dose therapies.
-Because beta2-adrenergic agonists and ipratropium bromide promote bronchodilation by different mechanisms, their beneficial effects are additive, hence combined use makes sense.
-For MDI use, alternate single puffs of
salbutamol and ipratropium bromide during recharge periods.